Akoya stockholders approve merger with Quanterix Corporation

Akoya Biosciences, Inc.

Over 85% quorum; 42,261,529 votes FOR the merger, 97,486 AGAINST, 62,166 abstentions.
Proposal to adopt Amended and Restated Agreement and Plan of Merger dated April 28, 2025 approved.
Adjournment proposal also passed but not needed as merger received sufficient votes.

item 5.07

Source: SEC EDGAR

accession 0001104659-25-066074

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.